» Authors » Minal A Patel

Minal A Patel

Explore the profile of Minal A Patel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 399
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stahl M, Derkach A, Farnoud N, Bewersdorf J, Robinson T, Famulare C, et al.
Am J Hematol . 2022 Oct; 98(1):79-89. PMID: 36251406
Measurable residual disease (MRD) is a powerful prognostic factor in acute myeloid leukemia (AML). However, pre-treatment molecular predictors of immunophenotypic MRD clearance remain unclear. We analyzed a dataset of 211...
2.
Spitzer B, Rutherford K, Gundem G, McGovern E, Millard N, Arango Ossa J, et al.
Clin Cancer Res . 2022 Jan; 28(8):1614-1627. PMID: 35078859
Purpose: Therapy-related myelodysplastic syndrome and acute leukemias (t-MDS/AL) are a major cause of nonrelapse mortality among pediatric cancer survivors. Although the presence of clonal hematopoiesis (CH) in adult patients at...
3.
Miles L, Bowman R, Merlinsky T, Csete I, Ooi A, Durruthy-Durruthy R, et al.
Nature . 2020 Oct; 587(7834):477-482. PMID: 33116311
Myeloid malignancies, including acute myeloid leukaemia (AML), arise from the expansion of haematopoietic stem and progenitor cells that acquire somatic mutations. Bulk molecular profiling has suggested that mutations are acquired...
4.
Tamari R, Rapaport F, Zhang N, McNamara C, Kuykendall A, Sallman D, et al.
Biol Blood Marrow Transplant . 2019 Jan; 25(6):1142-1151. PMID: 30625392
Mutational profiling has demonstrated utility in predicting the likelihood of disease progression in patients with myelofibrosis (MF). However, there is limited data regarding the prognostic utility of genetic profiling in...
5.
Xiao W, Bharadwaj M, Levine M, Farnhoud N, Pastore F, Getta B, et al.
Blood Adv . 2018 Dec; 2(23):3526-3539. PMID: 30530780
The genetic aberrations that drive mixed phenotype acute leukemia (MPAL) remain largely unknown, with the exception of a small subset of MPALs harboring and translocations. We performed clinicopathologic and genetic...
6.
Xiao W, Goldberg A, Famulare C, Devlin S, Nguyen N, Sim S, et al.
Haematologica . 2018 Dec; 104(7):1378-1387. PMID: 30523054
Measurable residual disease is associated with inferior outcomes in patients with acute myeloid leukemia (AML). Measurable residual disease monitoring enhances risk stratification and may guide therapeutic intervention. The European LeukemiaNet...
7.
McKenney A, Lau A, Hanasoge Somasundara A, Spitzer B, Intlekofer A, Ahn J, et al.
J Clin Invest . 2018 Sep; 128(10):4743. PMID: 30222137
No abstract available.
8.
McKenney A, Lau A, Hanasoge Somasundara A, Spitzer B, Intlekofer A, Ahn J, et al.
J Clin Invest . 2018 Jan; 128(2):789-804. PMID: 29355841
Patients with myeloproliferative neoplasms (MPNs) frequently progress to bone marrow failure or acute myeloid leukemia (AML), and mutations in epigenetic regulators such as the metabolic enzyme isocitrate dehydrogenase (IDH) are...
9.
Patel M, Modi H, Katyare S
Age (Dordr) . 2009 May; 29(1):41-9. PMID: 19424829
Effects of treatment with DHEA (0.2 or 1.0 mg/kg body weight for 7 days) on oxidative energy metabolism of rat liver mitochondria from old (18-24 month old) and young (8-10...
10.
Modi H, Katyare S, Patel M
J Membr Biol . 2007 Dec; 221(1):51-60. PMID: 18097631
Effects of ageing on the lipid/phospholipid profile of brain and liver mitochondria from rats were examined. In the brain mitochondria the contents of total phospholipid (TPL) and cholesterol (CHL) increased...